-+ 0.00%
-+ 0.00%
-+ 0.00%

Organon Canada Announces Availability Of NDUVRA To Treat Moderate To Severe Atopic Dermatitis

Benzinga·09/28/2026 12:09:47
Listen to the news

Organon Canada, a global healthcare company, today announces the approval and availability of NDUVRA® (tapinarof cream), 1%, for the topical treatment of moderate to severe atopic dermatitis in adult and pediatric patients 2 years of age and older.